EMGE Stock Chart & Stats
<$0.01
$0.00(0.00%)
At close: 4:00 PM EDT
<$0.01
$0.00(0.00%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume47.72K
Average Volume (3M)N/A
Market Cap
$42.70K
Enterprise Value$2.46M
Total Cash (Recent Filing)$2.11K
Total Debt (Recent Filing)$2.66M
Price to Earnings (P/E)―
Beta-222.17
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.00
Shares Outstanding426,951,100
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-0.12
Price to Sales (P/S)0.17
P/FCF Ratio-0.23
Enterprise Value/Market Cap57.67
Enterprise Value/Revenue7.37
Enterprise Value/Gross Profit14.34
Enterprise Value/Ebitda-6.62
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EMGE FAQ
What was Emergent Health Corp’s price range in the past 12 months?
Currently, no data Available
What is Emergent Health Corp’s market cap?
Emergent Health Corp’s market cap is $42.70K.
When is Emergent Health Corp’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Emergent Health Corp’s earnings last quarter?
Emergent Health Corp released its earnings results on Nov 21, 2022. The company reported -$0.003 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.003.
Is Emergent Health Corp overvalued?
According to Wall Street analysts Emergent Health Corp’s price is currently Overvalued.
Does Emergent Health Corp pay dividends?
Emergent Health Corp does not currently pay dividends.
What is Emergent Health Corp’s EPS estimate?
Emergent Health Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Emergent Health Corp have?
Emergent Health Corp has 426,951,100 shares outstanding.
What happened to Emergent Health Corp’s price movement after its last earnings report?
Emergent Health Corp reported an EPS of -$0.003 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Emergent Health Corp?
Currently, no hedge funds are holding shares in EMGE
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Emergent Health Corp
Emergent Health Corp. focuses on the creation and distribution of advanced regenerative medicine, alongside a variety of nutraceuticals and plant-derived nutritional supplements. The company's product portfolio features Vita-Stim, a potent nutrient formulated to strengthen the immune system, promote stem cell vitality, and support general well-being. Another key offering is Neuvitale, which not only assists in nourishing stem cells but also serves as a methyl donor to safeguard DNA integrity. For appetite regulation, they provide Hungarest, a dietary aid designed to manage hunger signals originating from both the brain and stomach. Additionally, EmergentO2 is available as a water oxygenator, aiming to elevate oxygen levels within the bloodstream. The firm also develops and markets several solutions for diminishing facial wrinkles. These products are distributed through a wide network of health food stores, pharmacies, and diverse other retail channels, reaching consumers throughout the United States and globally. Based in King of Prussia, Pennsylvania, Emergent Health Corp. transitioned to private ownership as of August 26, 2014.
Scinai Immunotherapeutics
―
Aditxt
―
NewcelX
―
Universe Pharmaceuticals
―
Virax Biolabs Group Ltd. Class A
―